10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
BRISTOL MYERS SQUIBB CO | ||
Ticker: BMY Fiscal Year: 2009 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2009 10-K (Filed: Feb 19, 2010) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2009 | Dec 31, 2008 | |
| ASSETS | ||
| Current Assets: | ||
| Cash and cash equivalents | $ 7,683 | 7,976 |
| Marketable securities | 831 | 289 |
| Receivables | 3,164 | 3,644 |
| Inventories | 1,413 | 1,765 |
| Deferred income taxes | 611 | 703 |
| Prepaid expenses | 256 | 320 |
| Total Current Assets | 13,958 | 14,697 |
| Property, plant and equipment | 5,055 | 5,405 |
| Goodwill | 5,218 | 4,827 |
| Other intangible assets | 2,865 | 1,151 |
| Deferred income taxes | 1,636 | 2,137 |
| Marketable securities | 1,369 | 188 |
| Other assets | 907 | 1,081 |
| Total Assets | 31,008 | 29,486 |
| LIABILITIES | ||
| Current Liabilities: | ||
| Short-term borrowings | 231 | 154 |
| Accounts payable | 1,711 | 1,535 |
| Accrued expenses | 2,785 | 2,974 |
| Deferred income | 237 | 277 |
| Accrued rebates and returns | 622 | 806 |
| U.S. and foreign income taxes payable | 175 | 347 |
| Dividends payable | 552 | 617 |
| Total Current Liabilities | 6,313 | 6,710 |
| Pension, postretirement and postemployment liabilities | 1,658 | 2,285 |
| Deferred income | 949 | 791 |
| U.S. and foreign income taxes payable | 751 | 466 |
| Other liabilities | 422 | 441 |
| Long-term debt | 6,130 | 6,585 |
| Total Liabilities | 16,223 | 17,278 |
| Commitments and contingencies (Note 24) | ||
| EQUITY | ||
| Bristol-Myers Squibb Company Shareholders' Equity: | ||
| Preferred stock, $2 convertible series, par value $1 per share: Authorized 10 million shares; issued and outstanding 5,515 in 2009 and 5,668 in 2008, liquidation value of $50 per share | 0 | 0 |
| Common stock, par value of $0.10 per share: Authorized 4.5 billion shares; 2.2 billion issued in both 2009 and 2008 | 220 | 220 |
| Capital in excess of par value of stock | 3,768 | 2,757 |
| Accumulated other comprehensive loss | (2,541) | (2,719) |
| Retained earnings | 30,760 | 22,549 |
| Less cost of treasury stock - 491 million common shares in 2009 and 226 million in 2008 | (17,364) | (10,566) |
| Total Bristol-Myers Squibb Company Shareholders' Equity | 14,843 | 12,241 |
| Noncontrolling interest | (58) | (33) |
| Total Equity | 14,785 | 12,208 |
| Total Liabilities and Equity | 31,008 | 29,486 |
| External Links | |
| BRISTOL MYERS SQUIBB CO (BMY) Fiscal Year 2009 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |